Summary
The NHS in England will begin offering the weight-loss injection Wegovy to more than a million people at risk of heart attacks and strokes. The treatment aims to reduce heart-related risks by mimicking a hormone that suppresses appetite and slows down food digestion. People with certain health conditions like heart issues or serious circulation problems will be eligible for this new treatment.
Key Facts
- The NHS will provide the weight-loss drug Wegovy for free to over a million people in England.
- Eligibility for the jab includes being at risk of heart attacks, strokes, or having serious circulation issues.
- Wegovy works by mimicking a hormone that makes people feel full, helping them lose weight.
- Trials show the injection reduces the risk of heart attacks and strokes by 20% when combined with existing heart medications.
- The treatment targets individuals with a Body Mass Index (BMI) classified as overweight or obese.
- People can self-administer the jab at home using a pen injector device.
- The NHS has an agreement with Novo Nordisk, the drugmaker, to ensure the treatment is cost-effective.
- Possible side effects include bloating, nausea, or discomfort, and doctors advise including healthy lifestyle changes.
